DermDocs

LivDerm
  • ٥٫٠ (٥)
  • تعليم
  • يتم التحديث كل أسبوعين
DermDocs

Revolutionizing Dermatology Education

  1. قبل ٦ أيام

    Exploring the Latest Updates in the Epidermolysis Bullosa Treatment Landscape

    This is the second episode of a two-part educational series to raise awareness of epidermolysis bullosa (EB) and the latest FDA-approved treatment options for this disease. Our host, Dr. Michael Lavery, a Pediatric Dermatologist and Clinical Assistant Professor at the University of Florida in Gainesville, FL, is joined by Dr. Joyce Teng, MD, PhD, Professor of Dermatology and Pediatrics at Stanford University School of Medicine in Stanford, CA, as they discuss the following topics: Setting the stage for treating a patient with EB Assessing EB severity and subtype to inform treatment Expert review of the current FDA-approved treatments and Strategies to close care gaps for EB patients

    ٣٢ من الدقائق

  2. ١١ جمادى الأولى

    Achieving More: How and When to Switch Systemic Therapies in Atopic Dermatitis?

    This is the sixth episode of our ongoing "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Achieving More: How and When to Switch Systemic Therapies in Atopic Dermatitis?", featuring Beth Sweney, PA-C discusses the following topics: Challenges in achieving treatment targets in AD Therapeutic inertia and clinical implications of inadequate response Comparative clinical data evaluating upadacitinib and dupilumab for treatment of AD Transitioning to systemic therapies from topical agents, immunosuppressives, and biologic therapies

    ٥٧ من الدقائق

  3. ٢٨ ربيع الآخر

    Exposing the Epidermolysis Bullosa Patient Burden and Challenges in Disease Management

    This is the first episode of a two-part educational series to raise awareness of epidermolysis bullosa (EB) and the latest FDA-approved treatment options for this disease. Our host, Dr. Joyce Teng, MD, PhD, Professor of Dermatology and Pediatrics at Stanford University School of Medicine in Stanford, CA, is joined by Dr. Michael Lavery, a Pediatric Dermatologist and Clinical Assistant Professor at the University of Florida in Gainesville, FL, as they discuss the following topics: Epidemiology and prevalence of EB Burden of disease and impact on patients' quality of life Gaps and challenges for patients with EB Assessing the current knowledge of clinicians and gaps in care recommendations

    ٣٢ من الدقائق

  4. ١٥ ربيع الآخر

    Chronic Hand Eczema: All Hands on Deck

    This podcast episode, sponsored by Leo Pharma, features LiVDerm faculty and esteemed dermatologists Dr. Christopher Bunick, MD, PhD, and Dr. Jonathan Silverberg, MD, PhD, MPH. As experts in all things concerning eczema, our faculty discuss the differentiating features and disease burden in patients suffering from chronic hand eczema (CHE) and review the current guidance for treatment, including these specific topics: Differentiating CHE from atopic dermatitis of the hands, including triggers, pathophysiology, and clinical presentation Expert guidance for accurate diagnosis and work-up of CHE patients Challenges and limitations of current therapeutic offerings The potential of a topical novel pan-JAK inhibitor for targeted treatment of CHE

    ٤٨ من الدقائق

  5. ٢٢ ربيع الأول

    Examining the Gaps and Challenges in Diagnosing and Treating Prurigo Nodularis

    This is the first episode of a two-part miniseries, "IL-31 Inhibition for Treatment of Prurigo Nodularis" series, supported by an educational grant from Galderma and hosted by prurigo nodularis (PN) expert Dr. Shawn Kwatra, MD. This episode, "Examining the Gaps and Challenges in Diagnosing and Treating Prurigo Nodularis", featuring expert dermatologist and neuroscientist Dr. Sarina Elmariah, MD, PhD, MPH, discusses the following topics: The lack of awareness and timely, correct diagnosis of PN patients Strategies for assessing patients with PN and alleviating disease symptoms and burden Examining the current expert guidance and available therapies for treating PN Looking to the future of PN diagnosis and targeted treatment

    ٤٩ من الدقائق

  6. ١٣ ربيع الأول

    Skirting Steroids in Atopic Dermatitis: New Therapies and Expert Strategies for Long-term Control

    This is the second episode of a two-part activity on "Skirting Steroids in Atopic Dermatitis", supported by an educational grant from Arcutis Biotherapeutics, Inc., and hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "New Therapies and Expert Strategies for Long-term Control", featuring expert dermatologist Dr. Jonathan Silverberg, MD, PhD, MPH, discusses the following topics: The pros and cons of steroid use in treating AD Targeted non-steroidal topical therapies approved by the FDA Relevant clinical efficacy and safety data for new and emerging non-steroidal topicals Recommendations for long-term symptom control in AD patients

    ١ من الساعات

  7. ٢ ربيع الأول

    Choosing the Right Path: JAK Inhibitors or Biologics for Atopic Dermatitis?

    This is the fifth episode of our new "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Choosing the Right Path: JAK Inhibitors or Biologics for Atopic Dermatitis?", featuring expert dermatologist Dr. Naiem Issa, MD, PhD, discusses the following topics: Mechanistic differences between JAKi and biologics for treatment of AD Clinical data supporting the safety of JAKi in head-to-head trials compared to biologics Pearls for prescribing JAKi to AD patients Strategies for choosing JAKi vs biologics based on safety and patient factors

    ٥٨ من الدقائق

  8. ١٠ صفر

    Skirting Steroids in Atopic Dermatitis: Dangers and Side Effects of Steroid Exposure in Treatment of AD

    This is the first episode of a two-part activity on "Skirting Steroids in Atopic Dermatitis", supported by an educational grant from Arcutis Biotherapeutics, Inc., and hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Dangers and Side Effects of Steroid Exposure in Treatment of AD", featuring expert dermatologist Dr. Peter Lio, MD, discusses the following topics: Side effects of topical and oral corticosteroid exposure Pearls and gaps in current guidelines for treatment of AD Identifying topical steroid withdrawal symptoms Safety and stewardship strategies for topical steroids Future of non-steroidal advanced topical therapies for AD   Record Date: 8/6/2024

    ٥٨ من الدقائق
مشاهدة الكل (٦٤)

٥
من ٥
‫٥ من التقييمات‬

حول

Revolutionizing Dermatology Education

المعلومات

  • صناع العمل
    LivDerm
  • سنوات النشاط
    ١٤٤١ هـ - ١٤٤٦ هـ
  • الحلقات
    ٦٤
  • التقييم
    ملائم
  • موقع البرنامج على الويب
    DermDocs

قد يعجبك أيضًا

  • PeDRA Pearls
    العلوم
    العلوم

    يتم التحديث أسبوعيًا

  • CME in Minutes: Education in Dermatology
    علوم حياة
    علوم حياة

    يتم التحديث أسبوعيًا

  • Derms and Conditions
    طب
    طب

    يتم التحديث كل أسبوعين

  • Dermasphere - The Dermatology Podcast
    طب
    طب

    مرتان في الشهر

  • Learn Skin with Dr. Raja and Dr. Hadar
    طب
    طب

    يتم التحديث أسبوعيًا

  • The Dr. Gundry Podcast
    التغذية
    التغذية

    يتم التحديث أسبوعيًا

للاستماع إلى حلقات ذات محتوى فاضح، قم بتسجيل الدخول.

اطلع على آخر مستجدات هذا البرنامج

قم بتسجيل الدخول أو التسجيل لمتابعة البرامج وحفظ الحلقات والحصول على آخر التحديثات.
تحديد بلد أو منطقة

أفريقيا والشرق الأوسط، والهند

آسيا والمحيط الهادئ

أوروبا

أمريكا اللاتينية والكاريبي

الولايات المتحدة وكندا